1. Home
  2. PDYNW vs GNLX Comparison

PDYNW vs GNLX Comparison

Compare PDYNW & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp

PDYNW

Palladyne AI Corp

N/A

Current Price

$0.01

Market Cap

0.0

Sector

Industrials

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.53

Market Cap

110.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYNW
GNLX
Founded
2017
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
110.4M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
PDYNW
GNLX
Price
$0.01
$2.53
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$17.25
AVG Volume (30 Days)
95.4K
297.3K
Earning Date
02-28-2025
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
108.86
9.47
EPS
N/A
N/A
Revenue
$5,246,000.00
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.00
$2.29
52 Week High
$0.29
$8.54

Technical Indicators

Market Signals
Indicator
PDYNW
GNLX
Relative Strength Index (RSI) 36.51 38.62
Support Level $0.00 $2.33
Resistance Level $0.03 $2.97
Average True Range (ATR) 0.00 0.16
MACD 0.00 -0.02
Stochastic Oscillator 2.01 11.61

Price Performance

Historical Comparison
PDYNW
GNLX

About PDYNW Palladyne AI Corp

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: